A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Sanofi Aventis Medications





Sanofi U.S. - Sanofi U.S. products

11/18/2014
07:26 | Author: Devin Garcia

Sanofi aventis
Sanofi U.S. - Sanofi U.S. products

and animals. We have extensive lines of prescription medicines and vaccines, as well as consumer health and animal health products.

If you have any questions, please call Content :

You are here : Subsections menu :

in the United States Products.

Quick navigation menu : Font size Welcome to Sanofi.

Last update: September 16, 2011.

We have extensive lines of prescription medicines and vaccines, as well as consumer health and animal health products. Sanofi is a diversified global healthcare leader, focused on developing products that meet the health needs of people and animals.

residents. This information is intended for U.S.

Comments (0)



Sanofi - Our products - Giving new hope to patients with key

11/17/2014
05:08 | Author: Caitlin White

Cafe pharma sanofi aventis
Sanofi - Our products - Giving new hope to patients with key

Sanofi proposes a diversified offer of prescription medicines, consumer healthcare products, generic drugs, vaccines and animal health products. With the new.

Our Products.

Giving new hope to patients with key therapeutic solutions You are here: Size Middle area.

Sanofi proposes a diversified offer of prescription medicines, consumer healthcare products, generic drugs, vaccines and animal health products. With the new Genzyme, Sanofi can now address the needs of patients with rare diseases and multiple sclerosis.

Sanofi produces 5 billion boxes of medicines per year. Right area:. How can the quality of each of them be guaranteed? What is the place of innovation in the industrial production? What is biotechnology? Philippe Luscan, Executive Vice-President Global Industrial Affairs, answers these questions in the video “ FROM PLANT TO PATIENT : A MEDICINE’S JOURNEY ”.

From plant to patient: a medecine's journey.

Comments (0)

Sanofi - Diabetes

9/16/2014
03:38 | Author: Evan Martin

Sanofi aventis
Sanofi - Diabetes

Building upon its century long history in this field, Sanofi is committed to improving global diabetes management through its integrated offering of treatments and.

Our Products.

Worldwide, 382 million people are currently living with diabetes, and this population will grow to 592 million before 2035 (1). Building upon its century long history in this field, Sanofi is committed to improving global diabetes management through its integrated offering of treatments and medical devices.

Our principal medicinal products in the field of diabetes are:

Tools content (print, share, increase/decrease text size): Size.

Sanofi has established agreements with several innovative companies to make new therapeutic solutions available to patients. For example, our innovative partnership with AgaMatrix has allowed us to bring to market the BGStar and iBGStar blood glucose monitors for patients taking insulin. MyStar Extra, a blood glucose monitors that provides the patient with an Ab1C estimation, is available since October 2013 in Italy, Spain and France. Right area:.

Giving new hope to patients with key therapeutic solutions You are here:

Furthermore, other diabetes treatments are currently in clinical development.

Comments (0)

Sanofi Aventis - MPR

7/15/2014
01:36 | Author: Evan Martin

Cafe pharma sanofi aventis
Sanofi Aventis - MPR

Drug Interactions · News · Drug News · Safety Alerts and Recalls · New Products · Drugs in the Pipeline · Drug Monograph Updates · Generics Sanofi Aventis.

By registering you agree with our Terms and Conditions and Privacy Policy.

It looks like we already have a MPR account for:

NEED HELP? Contact Customer Service » ENTER NEW PASSWORD Password* Re-Enter Password*

REGISTER FOR FREE WITH ONE OF YOUR SOCIAL ACCOUNTS.

NEED HELP? Contact Customer Service »

Sign in with your MPR account * Password*

By registering you agree with our Terms and Conditions and Privacy Policy.

Please confirm the information BELOW to link this account to your account.

SIGN IN WITH ONE OF YOUR SOCIAL ACCOUNTS.

I would like to receive relevant information via from Haymarket Media.

NEED HELP? Contact Customer Service »

Not you? Create an account for free »

Registration acknowledges the Terms and Conditions and Privacy Policy.

Keep me signed in Forgot your password?

Please take a moment to l us a little more about yourself, so we can bring you specialized clinical content that’s most valuable to you.

NEED HELP? Contact Customer Service »

I would like to receive relevant information via from Haymarket Media.

Enter your MPR registration address to receive a password reset link. *.

Please confirm the information BELOW before Signing In.

NEED HELP? Contact Customer Service »

NEED HELP? Contact Customer Service »

REGISTER FOR FREE WITH A MPR ACCOUNT.

Comments (0)

DailyMed - AVAPRO- irbesartan tablet

5/14/2014
01:30 | Author: Caitlin White

Cafe pharma sanofi aventis
DailyMed - AVAPRO- irbesartan tablet

Packager: sanofi-aventis U.S. LLC. Category: Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus.

Analysis of age, gender, and race subgroups of patients showed that men and women, and patients over and under 65 years of age, had generally similar responses. Irbesartan was effective in reducing blood pressure regardless of race, although the effect was somewhat less in blacks (usually a low-renin population).

Radioactivity was present in the rat and rabbit fetus during late gestation and in rat milk following oral doses of radiolabeled irbesartan.

Monitor lithium levels in patients receiving Avapro and lithium.

Comments (5)Read more